Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11466017
Heterocyclic inhibitors of PTPN11
granted -
US 11466274
Modified gapmer oligonucleotides and methods of use
granted -
US 11466018
TGF-β inhibitors
granted -
US 11464764
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
granted -
US 11466024
Bicylic compound acting as an inhibitor
granted -
US 11464784
Inhibition of aminocylase 3 (AA3) in the treatment of cancer
granted -
US 11465993
Water soluble novel cyanine fluorophore with tunable properties between near IR and SWIR region for in vivo imaging
granted -
US 11465995
Crystal and salt forms of tricyclic compound and preparation process thereof
granted -
US 11466015
Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine as sGC stimulators
granted -
US 11465994
MGluR7 agonist compounds for treating mGluR7-regulated diseases, disorders, or conditions
granted -
US 11466010
Toll-like receptor 8 (TLR8) specific antagonists and methods of making and uses thereof
granted -
US 11466071
HLA class I-restricted t cell receptors against mutated RAS
granted -
US 11465972
Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof
granted -
US 11464774
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
granted -
US 11464788
Oligomer-corticosteroid conjugates
granted -
US 11464856
Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers
granted -
US 11464845
Neisseria meningitidis immunogenic compositions
granted -
US 11464869
Non-adult human dosing of brentuximab vedotin
granted -
US 11464830
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11464801
Compositions and methods for treating cancer with anti-CD33 immunotherapy
granted -
US 11464807
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11464812
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11464802
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
granted -
US 11464841
TERT immunogenic compositions and methods of treatment using the same
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.